Gregory T. Bates
Keine laufenden Positionen mehr
Profil
Gregory T.
Bates worked as Senior VP-Regulatory Affairs & Quality at XenoPort, Inc. He then worked as Vice President-Regulatory Affairs at ATAI Life Sciences NV from 2019 to 2022.
Bates received his undergraduate degree from the University of California, Berkeley and his doctorate degree from the University of California, Davis.
Ehemalige bekannte Positionen von Gregory T. Bates
| Unternehmen | Position | Ende |
|---|---|---|
| ATAI LIFE SCIENCES N.V. | General Counsel | 01.05.2022 |
| XENOPORT, INC. | General Counsel | - |
Ausbildung von Gregory T. Bates
| University of California, Berkeley | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATAI LIFE SCIENCES N.V. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
